Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-11

Study Completion Date

2019-08-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is no prospective study published on the Essential Thrombocythemia and the correlation between this specific disease, its complications and the biological variations observed.

The aim of this study is to demonstrate a correlation between biological tests of haemostasis, as Multiplate analyser and thromboelastometry (ROTEM) and the occurrence of clinical complications, thrombosis and/or haemorrhage, in order to determine if this biological tests could be biological prognostic factors

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis

NCT03265054

Venous Thromboembolism (VTE)

UNKNOWN

Evaluation of the Inter-center Variability of the Measurement of Thrombin Generation by the ST Genesia System

NCT05422157

Patients Without a Medical History of Thrombosis or Hemorrhage Hemophilic Patient Patient With FV Leiden Mutation +2 more

COMPLETED

Incidence of Venous Thromboembolism and Professional Practices in Brest Area

NCT02895971

Venous Thromboembolism

COMPLETED

Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.

NCT06705829

Hemorrhagic Disorders Extrinsic Pathway Factor Deficiency Hepatocellular Insufficiency With Coagulopathy

RECRUITING

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

NCT05627375

Venous Thromboembolic Disease

RECRUITING PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thrombocythemia Essential

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with Essential Thrombocythemia

patients who come in consultation at diagnosis or during the follow-up for an Essential Thrombocythemia.

They will have biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)

Group Type OTHER

biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)

Intervention Type BIOLOGICAL

Patients will have blood samples at each consultation (2 or 3 sampling tubes) in order to carry out systematically three biological tests

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)

Patients will have blood samples at each consultation (2 or 3 sampling tubes) in order to carry out systematically three biological tests

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult aged more than 18 years old
* Patient followed in consultation for an Essential Thrombocythemia at diagnosis or during the follow-up
* Collection of the informed consent
* Patient affiliated to Social Security